{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:21:53Z","timestamp":1789356113335,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Society for Inherited Metabolic Disorders (SIMD)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.biocel.2013.12.009","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T01:15:25Z","timestamp":1389143725000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome"],"prefix":"10.1016","volume":"48","author":[{"given":"Ayman W.","family":"El-Hattab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa T.","family":"Emrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisak","family":"Chanprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Craigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Scaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2013.12.009_bib0005","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1253\/circj.CJ-10-0044","article-title":"Abnormal myocardial energy-production state in mitochondrial cardiomyopathy and acute response to l-arginine infusion. C-11 acetate kinetics revealed by positron emission tomography","volume":"74","author":"Arakawa","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.biocel.2013.12.009_bib0010","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1073\/pnas.0813409106","article-title":"Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia","volume":"106","author":"Atkuri","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.12.009_bib0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1152\/ajpendo.00068.2010","article-title":"Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide","volume":"299","author":"Bauchart-Thevret","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biocel.2013.12.009_bib0020","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1073\/pnas.90.16.7749","article-title":"Plasma arginine and citrulline kinetics in adults given adequate and arginine-free diets","volume":"90","author":"Castillo","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2013.12.009_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ajmg.1426","article-title":"Epidemiology and treatment of mitochondrial disorders","volume":"106","author":"Chinnery","year":"2001","journal-title":"Am J Med Gene"},{"key":"10.1016\/j.biocel.2013.12.009_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","article-title":"Almost all about citrulline in mammals","volume":"29","author":"Curis","year":"2005","journal-title":"Amino Acids"},{"key":"10.1016\/j.biocel.2013.12.009_bib0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/jn\/137.6.1646S","article-title":"Pharmacokinetics of arginine and related amino acids","volume":"137","author":"Cynober","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.biocel.2013.12.009_bib0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbadis.2012.01.010","article-title":"Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS","volume":"1822","author":"Desquiret-Dumas","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biocel.2013.12.009_bib0045","first-page":"437","article-title":"Renal arginine synthesis: studies in vitro and in vivo","volume":"259","author":"Dhanakoti","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ymgme.2012.01.016","article-title":"Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation","volume":"105","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.biocel.2013.12.009_bib0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2012.06.018","article-title":"Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders","volume":"107","author":"El-Hattab","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.biocel.2013.12.009_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mgene.2013.09.001","article-title":"The effect of citrulline and arginine supplementation on lactic acidemia in MELAS syndrome","volume":"1","author":"El-Hattab","year":"2013","journal-title":"Meta Gene"},{"key":"10.1016\/j.biocel.2013.12.009_bib0065","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/nm.2544","article-title":"Requirement of argininosuccinate lyase for systemic nitric oxide production","volume":"17","author":"Erez","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.biocel.2013.12.009_bib0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/niox.2001.0340","article-title":"Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase","volume":"5","author":"Flam","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biocel.2013.12.009_bib0075","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.HYP.23.6.1121","article-title":"Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions","volume":"23","author":"F\u00f6rstermann","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2013.12.009_bib0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/ijms14010394","article-title":"Nitric oxide synthesis is increased in cybrid cells with m.3243A>G mutation","volume":"14","author":"Gamba","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biocel.2013.12.009_bib0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1212\/WNL.42.3.545","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation","volume":"42","author":"Goto","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2013.12.009_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of exercise training on endothelium-derived nitric oxide function in humans","volume":"561","author":"Green","year":"2004","journal-title":"J Physiol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/088307389400900102","article-title":"Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts","volume":"9","author":"Hirano","year":"1994","journal-title":"J Child Neurol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0100","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1432-1033.2003.03559.x","article-title":"Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle","volume":"270","author":"Husson","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.biocel.2013.12.009_bib0105","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.WNL.0000151976.60624.01","article-title":"l-Arginine improves the symptoms of stroke-like episodes in MELAS","volume":"64","author":"Koga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2013.12.009_bib0110","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.wnl.0000220197.36849.1e","article-title":"Endothelial dysfunction in MELAS improved by l-arginine supplementation","volume":"66","author":"Koga","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2013.12.009_bib0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mito.2006.11.006","article-title":"MELAS and l-arginine therapy","volume":"7","author":"Koga","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biocel.2013.12.009_bib0120","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1093\/jn\/137.6.1621S","article-title":"Citrulline: a new player in the control of nitrogen homeostasis","volume":"137","author":"Moinard","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.biocel.2013.12.009_bib0125","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0007114507841110","article-title":"Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study","volume":"99","author":"Moinard","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.biocel.2013.12.009_bib0130","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1006\/bbrc.2000.3169","article-title":"Regulation of nitric oxide production by arginine metabolic enzymes","volume":"3","author":"Mori","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2013.12.009_bib0135","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/jn\/137.6.1602S","article-title":"Arginine metabolism: boundaries of our knowledge","volume":"137","author":"Morris","year":"2007","journal-title":"J Nutr"},{"key":"10.1016\/j.biocel.2013.12.009_bib0140","first-page":"87","article-title":"Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox\u201d","volume":"229","author":"Naini","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.biocel.2013.12.009_bib0145","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1242\/jcs.03062","article-title":"Nitric oxide and mitochondrial biogenesis","volume":"119","author":"Nisoli","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.biocel.2013.12.009_bib0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00688185","article-title":"Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy","volume":"74","author":"Ohama","year":"1987","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0155","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/niox.2001.0344","article-title":"Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats","volume":"5","author":"Oyadomari","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biocel.2013.12.009_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s004310051009","article-title":"The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia","volume":"55","author":"Parfait","year":"1999","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.biocel.2013.12.009_bib0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00023210-200620060-00002","article-title":"The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome. A review of treatment options","volume":"20","author":"Scaglia","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biocel.2013.12.009_bib0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.2007.02990.x","article-title":"Pharmacokinetic and pharmacodynamics properties of oral l-citrulline and l-arginine: impact on nitric oxide metabolism","volume":"65","author":"Schwedhelm","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0175","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(00)81957-1","article-title":"Perspectives on oxygen sensing","volume":"98","author":"Semenza","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2013.12.009_bib0180","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1242\/jeb.00361","article-title":"The caveolar nitric oxide synthase\/arginine regeneration system for NO production in endothelial cells","volume":"206","author":"Solomonson","year":"2003","journal-title":"J Exp Biol"},{"key":"10.1016\/j.biocel.2013.12.009_bib0185","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1196\/annals.1444.011","article-title":"Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome","volume":"1142","author":"Sproule","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.biocel.2013.12.009_bib0190","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2007.05.184","article-title":"The role of nitric oxide in muscle fibers with oxidative phosphorylation defects","volume":"359","author":"Tengan","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biocel.2013.12.009_bib0195","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","article-title":"Cellular ADMA: regulation and action","volume":"60","author":"Teerlink","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.biocel.2013.12.009_bib0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1124\/pr.55.2.3","article-title":"The pharmacology of nitric oxide in the peripheral nervous system of blood vessels","volume":"55","author":"Toda","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biocel.2013.12.009_bib0205","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.002964","article-title":"Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement","volume":"10","author":"Vattemi","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.biocel.2013.12.009_bib0210","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.freeradbiomed.2010.04.004","article-title":"Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease","volume":"49","author":"Villanueva","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.biocel.2013.12.009_bib0215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","article-title":"Mitochondrial diseases in man and mouse","volume":"283","author":"Wallace","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biocel.2013.12.009_bib0220","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1146\/annurev.bi.61.070192.005523","article-title":"Diseases of the mitochondrial DNA","volume":"61","author":"Wallace","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biocel.2013.12.009_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3360001","article-title":"Arginine metabolism: nitric oxide and beyond","volume":"336","author":"Wu","year":"1998","journal-title":"Biochem J"},{"key":"10.1016\/j.biocel.2013.12.009_bib0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2011.04.018","article-title":"In vivo functional brain imaging and a therapeutic trial of l-arginine in MELAS patients","volume":"1820","author":"Yoneda","year":"2012","journal-title":"Biochim Biophys Acta"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513003786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272513003786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:53:34Z","timestamp":1761202414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272513003786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":46,"alternative-id":["S1357272513003786"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2013.12.009","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria: Role of citrulline and arginine supplementation in MELAS syndrome","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2013.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}